H-1B sponsorship profile: Strand Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Strand Therapeutics Inc filed 24 Labor Condition Applications covering 24 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (24 certified of 24 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Strand Therapeutics Inc’s H-1B petitions range from $61,589 at the low end to $150,000 at the high end, with a petition-weighted average of $101,160. That range reflects the mix of occupations the company sponsors, led by Associate Scientist II of mRNA Process Development (3 petitions at $81,529 avg), followed by Senior Engineer (Full Stack Software) and Principal Associate Scientist of Immune Cell Engineering. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Strand Therapeutics Inc is headquartered in Boston, MA under NAICS code 3254, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Strand Therapeutics Inc ranks. By H-1B petition volume, Strand Therapeutics Inc is #8,821 of 119,880 employers nationally and #380 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.